April 02, 2017

Best of the States

Fight for access leads to Porter's breaking news in Bridgegate case

The Associated Press has been working for more than a year with a group of media organizations to lobby the federal court system in New Jersey to release pre-sentencing memos in criminal court cases to pull back the veil on what goes into judge’s sentencing decisions.

With two former allies of Gov. Chris Christie convicted in the Bridgegate case set to find out their fates last week, New Jersey law enforcement reporter David Porter was done waiting.

For his work collaborating with AP members in New Jersey to fight for public access to the memos and then being the first to report on them, Porter wins this week’s Best of the States award.

Guilty Parties

Nov. 25, 2016

Beat of the Week

(Honorable Mention)

$1,000 Vivitrol injections given inmate addicts to prevent relapses, but do the shots work?

for first spotting news in a single line in a state Medicaid waiver form, and then chasing down and chronicling in text and video how prisons in the U.S. are experimenting with $1,000-per-shot Vivitrol injections to keeps inmate from falling back into addictions, even without iron-clad medical evidence that they work. http://www.cbsnews.com/news/prisons-fight-opioids-...

Sept. 23, 2016

Best of the Week — First Winner

Pro-painkiller echo chamber shaped policy amid drug epidemic

Combine the capabilities of The Associated Press and the Center for Public Integrity, and this is what you can get: A two-part blockbuster that exposed the efforts of the opioid industry and allied groups to stymie limits on the use of its powerful drugs, and detailed how they spent more than $880 million on lobbying and political contributions over the past decade.

The genesis of the project was a conversation between Tom Verdin, editor of AP’s state government team, and Geoff Mulvihill, a member of that team. Mulvihill, based in Mount Laurel, N.J., has covered the opioid crisis sweeping the nation, and the two hit upon the idea of trying to determine the extent of the pharmaceutical industry’s exerting influence in state legislatures across the country.

Ap 16253810937091